CONCLUSIONS: Our study shows that FGF23 itself, but not its renal tissue resistance as reflected by FePi, is an important risk factor for clinical events in subjects with CKD stage 3-4.
PMID: 25700931 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)